X-38367353-A-C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 5P and 5B. PM1PM5PP2BP6BS2

The NM_000531.6(OTC):​c.140A>C​(p.Asn47Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000141 in 1,198,077 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 55 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N47H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., 2 hem., cov: 22)
Exomes 𝑓: 0.00014 ( 0 hom. 53 hem. )

Consequence

OTC
NM_000531.6 missense

Scores

2
8
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:3B:4

Conservation

PhyloP100: 4.59

Publications

7 publications found
Variant links:
Genes affected
OTC (HGNC:8512): (ornithine transcarbamylase) This nuclear gene encodes a mitochondrial matrix enzyme. The encoded protein is involved in the urea cycle which functions to detoxify ammonia into urea for excretion. Mutations in this enzyme lead to ornithine transcarbamylase deficiency, which causes hyperammonemia. [provided by RefSeq, May 2022]
OTC Gene-Disease associations (from GenCC):
  • ornithine carbamoyltransferase deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Laboratory for Molecular Medicine, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM1
In a hotspot region, there are 10 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 6 uncertain in NM_000531.6
PM5
Other missense variant is known to change same aminoacid residue: Variant chrX-38367353-A-T is described in ClinVar as [Pathogenic]. Clinvar id is 97113.Status of the report is criteria_provided_single_submitter, 1 stars.
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 266 curated pathogenic missense variants (we use a threshold of 10). The gene has 15 curated benign missense variants. Gene score misZ: 1.3274 (below the threshold of 3.09). Trascript score misZ: NaN (below the threshold of 3.09). GenCC associations: The gene is linked to ornithine carbamoyltransferase deficiency.
BP6
Variant X-38367353-A-C is Benign according to our data. Variant chrX-38367353-A-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 97112.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS2
High Hemizygotes in GnomAd4 at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTCNM_000531.6 linkc.140A>C p.Asn47Thr missense_variant Exon 2 of 10 ENST00000039007.5 NP_000522.3 P00480
OTCNM_001407092.1 linkc.140A>C p.Asn47Thr missense_variant Exon 4 of 12 NP_001394021.1
OTCXM_017029556.2 linkc.140A>C p.Asn47Thr missense_variant Exon 2 of 9 XP_016885045.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTCENST00000039007.5 linkc.140A>C p.Asn47Thr missense_variant Exon 2 of 10 1 NM_000531.6 ENSP00000039007.4 P00480
ENSG00000250349ENST00000465127.1 linkc.172-298768A>C intron_variant Intron 3 of 8 5 ENSP00000417050.1 B4E171

Frequencies

GnomAD3 genomes
AF:
0.000108
AC:
12
AN:
111423
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000167
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000207
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000158
AC:
29
AN:
183170
AF XY:
0.000192
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000312
Gnomad NFE exome
AF:
0.000281
Gnomad OTH exome
AF:
0.000222
GnomAD4 exome
AF:
0.000144
AC:
157
AN:
1086654
Hom.:
0
Cov.:
27
AF XY:
0.000150
AC XY:
53
AN XY:
352460
show subpopulations
African (AFR)
AF:
0.0000382
AC:
1
AN:
26182
American (AMR)
AF:
0.00
AC:
0
AN:
35198
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19301
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30165
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53916
European-Finnish (FIN)
AF:
0.000617
AC:
25
AN:
40509
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4109
European-Non Finnish (NFE)
AF:
0.000149
AC:
124
AN:
831548
Other (OTH)
AF:
0.000153
AC:
7
AN:
45726
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000108
AC:
12
AN:
111423
Hom.:
0
Cov.:
22
AF XY:
0.0000595
AC XY:
2
AN XY:
33589
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30570
American (AMR)
AF:
0.00
AC:
0
AN:
10443
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2640
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3588
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2657
European-Finnish (FIN)
AF:
0.000167
AC:
1
AN:
5971
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.000207
AC:
11
AN:
53124
Other (OTH)
AF:
0.00
AC:
0
AN:
1504
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.540
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000170
Hom.:
10
Bravo
AF:
0.0000756
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.000214
AC:
26
EpiCase
AF:
0.000273
EpiControl
AF:
0.000356

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:3Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Ornithine carbamoyltransferase deficiency Uncertain:3Benign:1
Feb 25, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 07, 2021
Genome-Nilou Lab
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 01, 2014
CSER _CC_NCGL, University of Washington
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research

- -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Pathogenic:1
-
GenMed Metabolism Lab
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

not specified Benign:1
Jun 11, 2020
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Asn47Thr variant in OTC is classified as likely benign because although it has been reported in 1 female with ornithine transcarbamylase (OTC) deficiency (PMID 16786505), it has also been identified in 14/75447 hemizygous males in gnomAD (http://gnomad.broadinstitute.org), which is an allele frequency too high to cause OTC deficiency. ACMG/AMP criteria applied:BS1, BS4. -

Inborn genetic diseases Benign:1
Oct 21, 2024
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

OTC-related disorder Benign:1
Aug 10, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.20
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.93
D
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.81
T
M_CAP
Pathogenic
0.73
D
MetaRNN
Uncertain
0.67
D
MetaSVM
Uncertain
0.73
D
MutationAssessor
Benign
1.1
L
PhyloP100
4.6
PrimateAI
Benign
0.44
T
PROVEAN
Uncertain
-2.5
D
REVEL
Uncertain
0.52
Sift
Uncertain
0.0050
D
Sift4G
Uncertain
0.0040
D
Polyphen
0.070
B
Vest4
0.73
MVP
0.90
MPC
0.41
ClinPred
0.083
T
GERP RS
5.4
Varity_R
0.52
gMVP
0.92
Mutation Taster
=49/51
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs67939655; hg19: chrX-38226606; API